Skip to main content

Find Clinical Trials

Home
Conditions
IDH Mutation

Clinical trial condition

IDH Mutation

Explore clinical trials studying IDH Mutation. Study availability and eligibility vary by location and protocol.

8 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

IDH Mutation trial results

Recruiting

Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma

NCT07260175

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations: Uniklinik RWTH Aachen Aachen, Germany

Universitätsklinikum Bonn Bonn, Germany

Uniklinikum Essen Essen, Germany

Krankenhaus Nordwest Frankfurt, Germany

View Trial Details

Recruiting

Window of Opportunity Study of DSP-0390 in Gliomas

NCT06636162

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +14 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Recruiting

Patient Voice in the Treatment of Low-grade Gliomas: Use of Patient-reported Outcomes, Vorasidenib and Radiotherapy Compared

NCT07547163

Conditions: Glioma, Glioma of Brain, IDH Mutation, +9 more
Locations: Fondazione IRCCS Istituto Neurologico Carlo Besta Milan, Italy

View Trial Details

Recruiting

All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma

NCT05345002

Conditions: Astrocytoma, Glioma, IDH Mutation, +8 more
Locations: University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

Metabolic Characterization of Space Occupying Lesions of the Brain

NCT04233788

Conditions: Brain Diseases, Brain Neoplasms, Brain Tumor, +14 more
Locations: Institute for Diagnostic and Interventional Neuroradiology, University Hospital Bern Bern, Switzerland

View Trial Details

Not Yet Recruiting

Neurocognitive Assessment CNSL and LGG

NCT07710131

Conditions: Brain Diseases, Brain Neoplasms, Brain Tumor, +13 more
Locations: Not specified

View Trial Details

Completed

Talazoparib - Carboplatin for Recurrent High-grade Glioma With DDRd

NCT04740190

Conditions: Astrocytoma, Glioblastoma, Glioma, +12 more
Locations: Department of Clinical Oncology Hong Kong

View Trial Details

Active, Not Recruiting

Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors

NCT03991832

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +10 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details